IGF1 and metabolic dysfunction-associated steatotic liver disease: NAFLD displays reduced IGF-1 levels and elevated levels of IGF-binding proteins (IGFBPs), whereas advanced fibrosis is associated with further IGF-1 decline and heightened CKD risk [139].